Spots Global Cancer Trial Database for Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
Official Title: Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics
Study ID: NCT06260410
Conditions
Study Description
Brief Summary: This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and safety data on the drug, gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Erasmus MC, Rotterdam, Zuid-Holland, Netherlands
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
